Sue Gail Eckhardt Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

Sue Gail Eckhardt is of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 16,000 shares of SYRS, which is worth approximately $3,200. The most recent transaction as insider was on Jun 05, 2024, when has been sold 4,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16K

0% 3M change

33.33% 12M change

Total Value Held $3,200

Sue Gail Eckhardt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2024	BUY Grant, award, or other acquisition	-	4,000 Added 20.0%	16,000 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	4,000 Added 25.0%	12,000 Common Stock
Sep 16 2022	BUY Grant, award, or other acquisition	-	8,000 Added 50.0%	8,000 Common Stock

Also insider at

EXEL

EXELIXIS, INC. Healthcare

Director

SGE